These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 16730647)

  • 1. Delivery of substances and their target-specific topical activation.
    Pipkorn R; Waldeck W; Spring H; Jenne JW; Braun K
    Biochim Biophys Acta; 2006 May; 1758(5):606-10. PubMed ID: 16730647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BioShuttle mobility in living cells studied with high-resolution FCS & CLSM methodologies.
    Braun K; Beining M; Wiessler M; Lammers T; Pipkorn R; Hennrich U; Nokihara K; Semmler W; Debus J; Waldeck W
    Int J Med Sci; 2012; 9(5):339-52. PubMed ID: 22811608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzyme-triggered delivery of chlorambucil from conjugates based on the cell-penetrating peptide BP16.
    Soler M; González-Bártulos M; Figueras E; Ribas X; Costas M; Massaguer A; Planas M; Feliu L
    Org Biomol Chem; 2015 Feb; 13(5):1470-80. PubMed ID: 25474438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient delivery of payload into tumor cells in a controlled manner by TAT and thiolytic cleavable PEG co-modified liposomes.
    Kuai R; Yuan W; Qin Y; Chen H; Tang J; Yuan M; Zhang Z; He Q
    Mol Pharm; 2010 Oct; 7(5):1816-26. PubMed ID: 20701288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cathepsin substrates as cleavable peptide linkers in bioconjugates, selected from a fluorescence quench combinatorial library.
    Peterson JJ; Meares CF
    Bioconjug Chem; 1998; 9(5):618-26. PubMed ID: 9736496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysosomally cleavable peptide-containing polymersomes modified with anti-EGFR antibody for systemic cancer chemotherapy.
    Lee JS; Groothuis T; Cusan C; Mink D; Feijen J
    Biomaterials; 2011 Dec; 32(34):9144-53. PubMed ID: 21872328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-responsive cell-penetrating peptide conjugated mesoporous silica quantum dot nanocarriers for controlled release of nucleus-targeted drug molecules and real-time intracellular fluorescence imaging of tumor cells.
    Li J; Liu F; Shao Q; Min Y; Costa M; Yeow EK; Xing B
    Adv Healthc Mater; 2014 Aug; 3(8):1230-9. PubMed ID: 24550203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytotoxic activity of a tumor protease-activated pore-forming toxin.
    Potrich C; Tomazzolli R; Dalla Serra M; Anderluh G; Malovrh P; Macek P; Menestrina G; Tejuca M
    Bioconjug Chem; 2005; 16(2):369-76. PubMed ID: 15769091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of radiometal-labeled and fluorescent cell-permeating peptide-PNA conjugates for targeting the bcl-2 proto-oncogene.
    Gallazzi F; Wang Y; Jia F; Shenoy N; Landon LA; Hannink M; Lever SZ; Lewis MR
    Bioconjug Chem; 2003; 14(6):1083-95. PubMed ID: 14624621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Stable and Cleavable O-Linked Spacer for Drug Delivery Systems.
    Ito K; Tatsumi T; Takahashi K; Shimizu Y; Yamatsugu K; Kanai M
    Chem Pharm Bull (Tokyo); 2020 Mar; 68(3):212-215. PubMed ID: 31189762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The transdermal inhibition of melanogenesis by a cell-membrane-permeable peptide delivery system based on poly-arginine.
    Ookubo N; Michiue H; Kitamatsu M; Kamamura M; Nishiki T; Ohmori I; Matsui H
    Biomaterials; 2014 May; 35(15):4508-16. PubMed ID: 24602570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.
    Durairaj C; Kadam RS; Chandler JW; Hutcherson SL; Kompella UB
    Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5804-16. PubMed ID: 20484584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of attachment site on stability of cleavable antibody drug conjugates.
    Dorywalska M; Strop P; Melton-Witt JA; Hasa-Moreno A; Farias SE; Galindo Casas M; Delaria K; Lui V; Poulsen K; Loo C; Krimm S; Bolton G; Moine L; Dushin R; Tran TT; Liu SH; Rickert M; Foletti D; Shelton DL; Pons J; Rajpal A
    Bioconjug Chem; 2015 Apr; 26(4):650-9. PubMed ID: 25643134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observing proteases in living cells.
    Moin K; Demchik L; Mai J; Duessing J; Peters C; Sloane BF
    Adv Exp Med Biol; 2000; 477():391-401. PubMed ID: 10849765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of enzymatically cleavable prodrugs derived from dendritic polyglycerol.
    Calderón M; Graeser R; Kratz F; Haag R
    Bioorg Med Chem Lett; 2009 Jul; 19(14):3725-8. PubMed ID: 19553109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas).
    Takayama K; Nakase I; Michiue H; Takeuchi T; Tomizawa K; Matsui H; Futaki S
    J Control Release; 2009 Sep; 138(2):128-33. PubMed ID: 19465072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracellular cargo delivery by an octaarginine transporter adapted to target prostate cancer cells through cell surface protease activation.
    Goun EA; Shinde R; Dehnert KW; Adams-Bond A; Wender PA; Contag CH; Franc BL
    Bioconjug Chem; 2006; 17(3):787-96. PubMed ID: 16704219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules.
    Lee WR; Shen SC; Al-Suwayeh SA; Yang HH; Yuan CY; Fang JY
    J Control Release; 2011 Aug; 153(3):240-8. PubMed ID: 21435360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin-B induced controlled release from peptide-capped mesoporous silica nanoparticles.
    de la Torre C; Mondragón L; Coll C; Sancenón F; Marcos MD; Martínez-Máñez R; Amorós P; Pérez-Payá E; Orzáez M
    Chemistry; 2014 Nov; 20(47):15309-14. PubMed ID: 25303093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescent dendrimers with a peptide cathepsin B cleavage site for drug delivery applications.
    Fuchs S; Otto H; Jehle S; Henklein P; Schluter AD
    Chem Commun (Camb); 2005 Apr; (14):1830-2. PubMed ID: 15795757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.